COPD is a group of progressive lung diseases that includes emphysema and chronic bronchitis. Despite affecting an estimated 32 million people in the United States, as many as half are unaware they ...

The COPD approval marks the fifth Nucala has received from the FDA, following green lights in severe asthma, chronic ...

University of Alabama at Birmingham-led researchers have refined and validated a new framework for diagnosing chronic ...

The relationship between chronic obstructive pulmonary disease (COPD) and chronic bronchitis (CB ... syndromes and will discuss the epidemiology, pathophysiology, etiology and clinical features ...

Chronic obstructive pulmonary disease (COPD) affects millions of Americans, with new data from the National Center for Health Statistics showing the condition becomes increasingly common as people age ...

Current recommendations for diagnosis of COPD in patients with respiratory symptoms require detection of airflow obstruction ...

Using imaging and respiratory symptoms, researchers identified up to 15.4% of individuals without airflow obstruction as ...

Patients with COPD and type 2 inflammation receiving mepolizumab vs. placebo had decreased moderate and severe exacerbation ...

Incorporating chest CT imaging and respiratory symptoms into the chronic obstructive pulmonary disease (COPD) diagnostic ...

COPD is an inflammatory lung disease, comprising several conditions, including chronic bronchitis and emphysema, and can be caused by genetics and irritants like smoke or pollution. The disease ...

There are two types of COPD: emphysema and chronic bronchitis. Emphysema is a condition that damages the air sacs of the lungs, making it harder to breathe. Chronic bronchitis causes long-term ...